Kieffer Tara Lynn (CIK 0001834835)

Latest company ownership

ENTA - ENANTA PHARMACEUTICALS INC
Role: Chief Product Strategy Officer
Shares held
32,726
Last filed at
Dec 5, 2025
Confidence Score
44.8
2025Q4
Confidence Score History
2022Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 5, 2025 Dec 5, 2025 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 46.3 -2,106 -6.44% ✗ $30K
Dec 1, 2025 Dec 3, 2025 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 46.3 -753 -2.25% ✗ $10.6K
Feb 12, 2025 Feb 14, 2025 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 91.3 +4,174 14.24% ✗ $18.6K
Dec 6, 2024 Dec 10, 2024 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 46.3 -2,283 -7.23% ✗ $18.4K
Dec 1, 2024 Dec 3, 2024 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 47.5 -753 -2.33% ✗ $6.5K
Jun 17, 2024 Jun 17, 2024 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 20.0 -7,266 -18.35% ✓ $89.6K
Feb 12, 2024 Feb 14, 2024 ENANTA PHARMACEUTICALS INC Chief Product Strategy Officer Sell 86.3 +2,347 6.30% ✗ $12.1K
Dec 5, 2023 Dec 6, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, New Prod. Strat. & Dev Sell 46.3 -2,125 -5.40% ✗ $20.5K
Dec 1, 2023 Dec 5, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, New Prod. Strat. & Dev Sell 47.5 -753 -1.88% ✗ $7.1K
Feb 13, 2023 Feb 15, 2023 ENANTA PHARMACEUTICALS INC Sr. VP, New Product Dev. Sell 97.5 +14,272 55.18% ✗ $354.9K
Dec 1, 2022 Dec 5, 2022 ENANTA PHARMACEUTICALS INC Sr. VP, New Product Dev. Sell 46.3 -498 -1.89% ✗ $22.1K
Feb 14, 2022 Feb 15, 2022 ENANTA PHARMACEUTICALS INC Sr. VP, New Product Dev. Sell 91.3 +1,064 15.65% ✗ $34.5K